FastAb proposes a rapid and efficient system, in auto-test format, to detect the immune status as regards multiple infections simultaneously. The system allows the automated gathering of information on the prevalence and seroconversion of the global population to several diseases; it thus provides epidemic intelligence that will help to design and implement strategies to fight epidemics and to plan pharmaceutical developments.
The FastAb system is possible thanks to the advantages provided by the MELISA technology, developed and patented by CIC biomaGUNE. They include low production costs, design flexibility, detection sensitivity and the reagent stability.
The general population is the target of this auto-test detection system. The epidemic data gathered are for the national health systems and the pharmaceutical industry.
Fill in this form and we will contact you if you want to take part in this initiative – either by contributing technology assets or if you are a talent promoter capable of turning them into business projects.
Entrepreneurship
Entrepreneurship
Entrepreneurship
EntrepreneurshipFor SMEs, for diversifying markets, internships abroad, international tenders, non-reimbursable subsidies to consolidate exports, subsidies for deployments or specific training in internationalisation.
You’re interested, right?
